Robot-Assisted HIIT Beats Treadmill Training for Chronic Stroke Gait Recovery
An 8-week RCT shows combining high-intensity interval training with robotic gait therapy significantly outperforms treadmill therapy in chronic stroke patients.
Summary
A randomized controlled trial of 44 chronic stroke patients found that high-intensity interval training (HIIT) combined with robot-assisted gait therapy (RAGT) using an end-effector robot produced significantly greater improvements than standard treadmill gait therapy across multiple outcomes. After 24 sessions over 8 weeks, the RAGT-HIIT group showed large gains in walking speed (10MWT, d=1.2), functional ambulation, balance, lower limb motor function, walking endurance, and cardiorespiratory fitness (VO₂max). Treadmill therapy also improved some measures within-group, but between-group differences consistently favored the robotic HIIT approach, suggesting this novel combination may meaningfully enhance rehabilitation for those in the chronic phase of stroke recovery.
Detailed Summary
Stroke remains the third leading cause of long-term disability globally, and improving gait and functional independence during the chronic phase is both clinically important and economically valuable. While robot-assisted gait therapy (RAGT) and high-intensity interval training (HIIT) have individually shown promise in stroke rehabilitation, this study is among the first to rigorously test their combination in a randomized controlled trial.
Researchers at Asan Medical Center (Seoul, South Korea) enrolled 48 chronic stroke patients (>6 months post-stroke, FAC ≤3) and randomized them 1:1 to either standard treadmill gait therapy or RAGT with HIIT using the Morning Walk® end-effector robot. Both groups trained 30 minutes per session, three times weekly for 8 weeks (24 sessions total). The treadmill group targeted a Borg RPE of 13–15. The RAGT-HIIT group alternated 2-minute moderate-intensity intervals (RPE 10–12) with 3-minute high-intensity intervals (RPE >14), with intensity regulated using the Karvonen heart rate reserve formula and adjusted by changing the robot's training mode (ground walking, stair ascending, or descending) or cadence (30–70 steps/min).
Of 48 enrolled participants, 44 completed the study (91.7%). Between-group comparisons showed the RAGT-HIIT group achieved significantly superior results on the primary outcome—10-meter walk test (p<0.001, Cohen's d=1.2, a large effect)—as well as the Functional Ambulation Category (p=0.009), Berg Balance Scale (p=0.015), 2-minute walk test (p=0.005), and Fugl-Meyer Assessment–Lower Extremity (p<0.001). Within the intervention group, both 2MWT (p<0.001) and VO₂max (p=0.005) improved significantly. Changes in lean body mass were minimal in both groups. An intention-to-treat sensitivity analysis confirmed these findings.
The superior results likely reflect the synergistic combination of task-specific, high-repetition robotic movement with the cardiovascular and neuromuscular demands of HIIT. The robot's ability to precisely control cadence and mode enables consistent intensity titration that is difficult to replicate on a treadmill with hemiplegic patients. Improved cardiorespiratory fitness (VO₂max) in the RAGT-HIIT group also suggests systemic aerobic adaptation beyond gait mechanics alone.
These findings carry meaningful implications for chronic stroke rehabilitation programs. The chronic phase of stroke has historically seen diminishing therapeutic gains, making effective interventions particularly valuable. The combination of HIIT and RAGT appears to address both neuromotor and cardiovascular deficits simultaneously, offering a compelling approach to intensifying outpatient rehabilitation without increasing session time.
Key Findings
- RAGT-HIIT produced a large effect on 10-meter walk test speed vs. treadmill (p<0.001, Cohen's d=1.2).
- Functional ambulation, balance (BBS), and lower limb motor function (FMA-LE) all improved significantly more in the robot group.
- VO₂max increased significantly within the RAGT-HIIT group (p=0.005), indicating aerobic fitness gains.
- Both 2-minute walk test and FAC showed significant between-group superiority for RAGT-HIIT (p=0.005 and p=0.009).
- Lean body mass changes were negligible in both groups despite 8 weeks of training.
Methodology
Prospective RCT (n=48, 44 completers) at a tertiary hospital; participants randomized 1:1 to treadmill gait therapy or RAGT-HIIT using the Morning Walk® end-effector robot for 24 sessions over 8 weeks. Primary outcome was 10MWT; nonparametric statistics (Mann-Whitney U, Wilcoxon signed-rank) used given non-normal distributions; ITT sensitivity analysis applied LOCF for dropouts.
Study Limitations
The study was unblinded and conducted at a single tertiary center, limiting generalizability. The pre-treatment FMA-LE score was significantly higher in the control group, representing a potential baseline imbalance favoring the intervention group's relative gains. The sample size was modest (n=22 per group) and the 8-week follow-up does not address durability of improvements.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
